Fresenius Medical Care AG & Co. KGaA (FMCQF)
USD 45.38
(0.0%)
USD 45.38
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 19.45 Billion | 20.75 Billion | 20.02 Billion | 21.85 Billion | 19.61 Billion | 16.54 Billion |
| Cost of Revenue | 14.52 Billion | 15.07 Billion | 14.25 Billion | 15.07 Billion | 13.56 Billion | 11.39 Billion |
| Gross Profit | 4.92 Billion | 5.68 Billion | 5.77 Billion | 6.78 Billion | 6.05 Billion | 5.15 Billion |
| Operating Expenses | 3.55 Billion | 3.8 Billion | 3.49 Billion | 4.08 Billion | 3.65 Billion | 2.81 Billion |
| Selling, General and Administrative Expenses | 3.19 Billion | 3.56 Billion | 3.24 Billion | 3.84 Billion | 3.46 Billion | 2.68 Billion |
| Research and Development Expenses | 231.97 Million | 244.68 Million | 250.94 Million | 237.09 Million | 188.61 Million | 133.61 Million |
| Other Expenses | 127.26 Million | - | - | - | - | - |
| Cost and Expenses | 18.08 Billion | 18.88 Billion | 17.75 Billion | 19.15 Billion | 17.21 Billion | 14.21 Billion |
| Operating Income | 1.36 Billion | 1.87 Billion | 2.27 Billion | 2.7 Billion | 2.4 Billion | 2.33 Billion |
| Interest Expense | 424.64 Million | 373.92 Million | 404.97 Million | 503.05 Million | 527.56 Million | 448.47 Million |
| Income Tax Expense | 300.55 Million | 347.78 Million | 401.04 Million | 612.45 Million | 450.81 Million | 511.07 Million |
| Earnings before Tax | 1.03 Billion | 1.23 Billion | 1.68 Billion | 2.25 Billion | 1.98 Billion | 2.66 Billion |
| Net Income | 498.99 Million | 673.4 Million | 969.3 Million | 1.16 Billion | 1.19 Billion | 1.98 Billion |
| Earnings Per Share Basic | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | 6.47 |
| Earnings Per Share Diluted | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | 6.45 |
| Weighted Average Shares Outstanding | 293.52 Million | 293.24 Million | 292.94 Million | 294.05 Million | 302.69 Million | 306.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 293.41 Million | 293.24 Million | 293.06 Million | 294.27 Million | 302.74 Million | 307.22 Million |
| Gross Margin | 0.25 | 0.27 | 0.29 | 0.31 | 0.31 | 0.31 |
| EBIT Margin | 0.15 | 0.18 | 0.20 | 0.21 | 0.21 | 0.19 |
| Profit Margin | 0.03 | 0.03 | 0.05 | 0.05 | 0.06 | 0.12 |
| EBITDA | 2.93 Billion | 3.41 Billion | 3.54 Billion | 4.13 Billion | 3.92 Billion | 2.9 Billion |
| Earnings Before Tax Margin | 0.07 | 0.09 | 0.11 | 0.12 | 0.12 | 0.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.76 Billion | 4.72 Billion | 5.5 Billion | 19.45 Billion | 5.21 Billion | 5.26 Billion |
| Cost of Revenue | 3.59 Billion | 3.55 Billion | 4.01 Billion | 14.52 Billion | 3.91 Billion | 3.95 Billion |
| Gross Profit | 1.16 Billion | 1.17 Billion | 1.49 Billion | 4.92 Billion | 1.29 Billion | 1.3 Billion |
| Operating Expenses | 813.79 Million | 957 Million | 979.56 Million | 3.44 Billion | 830.27 Million | 877.27 Million |
| Selling, General and Administrative Expenses | 768.2 Million | 776 Million | 906.71 Million | - | 774.2 Million | 814.9 Million |
| Research and Development Expenses | 45.58 Million | 48 Million | 72.84 Million | - | 56.06 Million | 62.37 Million |
| Other Expenses | -75.35 Million | -133 Million | - | - | - | - |
| Cost and Expenses | 4.41 Billion | 4.5 Billion | 4.99 Billion | 17.97 Billion | 4.74 Billion | 4.83 Billion |
| Operating Income | 352.69 Million | 217 Million | 510.48 Million | 1.36 Billion | 468.88 Million | 428.57 Million |
| Interest Expense | 103 Million | 103.85 Million | 123.47 Million | 424.64 Million | 120.35 Million | 114.17 Million |
| Income Tax Expense | 99.01 Million | 40 Million | 94.92 Million | 300.55 Million | 93.49 Million | 88.5 Million |
| Earnings before Tax | 306.81 Million | 129 Million | 353.19 Million | 1.03 Billion | 225.02 Million | 248.48 Million |
| Net Income | 187 Million | 70.95 Million | 187.92 Million | 498.99 Million | 84.35 Million | 140 Million |
| Earnings Per Share Basic | 0.64 | 0.24 | 0.64 | - | 0.29 | 0.48 |
| Earnings Per Share Diluted | 0.64 | 0.24 | 0.64 | - | 0.29 | 0.48 |
| Weighted Average Shares Outstanding | 293.41 Million | 293.41 Million | 293.41 Million | 293.41 Million | 293.41 Million | 293.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 293.41 Million | 293.41 Million | 293.41 Million | 293.41 Million | 293.41 Million | 293.41 Million |
| Gross Margin | 0.24 | 0.25 | 0.27 | 0.25 | 0.25 | 0.25 |
| EBIT Margin | 0.15 | 0.15 | 0.17 | - | 0.17 | 0.17 |
| Profit Margin | 0.04 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 |
| EBITDA | 736.45 Million | 729 Million | 954.66 Million | - | 883.93 Million | 871.48 Million |
| Earnings Before Tax Margin | 0.07 | 0.05 | 0.09 | 0.07 | 0.09 | 0.08 |
FRAM-B
PRCNF
7229
GOZ
CRTTF
NMT